Emanuele Andreano earned his Bachelor of Science (B.Sc.) in Biotechnology from University of Siena (Italy) in 2013. Afterward he was awarded a LLP-Erasmus Placement scholarship at Newcastle University (UK) where he also obtained his Master degree of Research (M.Res.) in Immunobiology (2015). In the Fall of 2015, Emanuele moved back to Siena where he started his Ph.D. with the University of Siena and Glaxo Smith Kline (GSK) Vaccines Siena (Italy) and Rockville, Maryland (USA) which he has been awarded in April of 2019. During this period he gained extensive experience on single cell sorting of antigen specific memory B cells and isolation, cloning, expression and functional/structural characterization of human monoclonal antibodies. This experience has been used to unravel the human healthy donors functional antibody repertoire against the respiratory syncytial virus (RSV) fusion protein (F-protein). Emanuele is currently an European Research Council (ERC) Post-Doctoral fellow within the research group led by Dr. Rino Rappuoli at Fondazione Toscana Life Sciences in Siena. Here, he works on the isolation of human monoclonal antibodies against bacterial pathogens. The aim of his Post-Doc is to fight one of the biggest global threat for human health of our days which is antimicrobial resistance (AMR).